Literature DB >> 15269266

Corticotropin-releasing factor receptors CRF1 and CRF2 exert both additive and opposing influences on defensive startle behavior.

Victoria B Risbrough1, Richard L Hauger, Amanda L Roberts, Wylie W Vale, Mark A Geyer.   

Abstract

The corticotropin-releasing factor (CRF) receptors (CRF1 and CRF2) are crucial mediators of physiological and behavioral responses to stress. In animals, CRF1 appears to primarily mediate CRF-induced anxiety-like responses, but the role of CRF2 during stress is still unclear. Here we report the effects of CRF1 and CRF2 on the magnitude and plasticity of defensive startle responses in mice. Startle plasticity is measured by inhibition of startle by sensory stimuli, i.e., prepulse inhibition (PPI), and is disrupted in patients with panic or posttraumatic stress disorders in which CRF neurotransmission may be overactive. Pharmacological blockade of CRF1 reversed both CRF-induced increases in startle and CRF-induced deficits in PPI. CRF2 blockade attenuated high-dose but not low-dose CRF-induced increases in startle and reduced PPI. Conversely, activation of CRF2 enhanced PPI. CRF had no effect on startle and increased PPI in CRF1 knock-out mice. These data indicate that CRF receptors act in concert to increase the magnitude of defensive startle yet in opposition to regulate the flexibility of startle. These data support a new model of respective CRF receptor roles in stress-related behavior such that, although both receptors enhance the magnitude of defensive responses, CRF1 receptors contravene, whereas CRF2 receptors enhance, the impact of sensory information on defensive behavior. We hypothesize that excessive CRF1 activation combined with reduced CRF2 signaling may contribute to information processing deficits seen in panic and posttraumatic stress disorder patients and support CRF1-specific pharmacotherapy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15269266      PMCID: PMC6729883          DOI: 10.1523/JNEUROSCI.5760-03.2004

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  83 in total

1.  Enhanced nucleus accumbens dopamine and plasma corticosterone stress responses in adult rats with neonatal excitotoxic lesions to the medial prefrontal cortex.

Authors:  W G Brake; G Flores; D Francis; M J Meaney; L K Srivastava; A Gratton
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Effects of corticotropin-releasing factor on neuronal activity in the serotonergic dorsal raphe nucleus.

Authors:  L G Kirby; K C Rice; R J Valentino
Journal:  Neuropsychopharmacology       Date:  2000-02       Impact factor: 7.853

3.  Mice deficient for corticotropin-releasing hormone receptor-2 display anxiety-like behaviour and are hypersensitive to stress.

Authors:  T L Bale; A Contarino; G W Smith; R Chan; L H Gold; P E Sawchenko; G F Koob; W W Vale; K F Lee
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

4.  Deletion of crhr2 reveals an anxiolytic role for corticotropin-releasing hormone receptor-2.

Authors:  T Kishimoto; J Radulovic; M Radulovic; C R Lin; C Schrick; F Hooshmand; O Hermanson; M G Rosenfeld; J Spiess
Journal:  Nat Genet       Date:  2000-04       Impact factor: 38.330

Review 5.  A role for corticotropin releasing factor and urocortin in behavioral responses to stressors.

Authors:  G F Koob; S C Heinrichs
Journal:  Brain Res       Date:  1999-11-27       Impact factor: 3.252

6.  Reduced sensory gating of the P1 potential in rape victims and combat veterans with posttraumatic stress disorder.

Authors:  R D Skinner; L M Rasco; J Fitzgerald; C N Karson; M Matthew; D K Williams; E Garcia-Rill
Journal:  Depress Anxiety       Date:  1999       Impact factor: 6.505

7.  Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: differential roles of CRF receptors 1 and 2.

Authors:  J Radulovic; A Rühmann; T Liepold; J Spiess
Journal:  J Neurosci       Date:  1999-06-15       Impact factor: 6.167

8.  The ligand-selective domains of corticotropin-releasing factor type 1 and type 2 receptor reside in different extracellular domains: generation of chimeric receptors with a novel ligand-selective profile.

Authors:  F M Dautzenberg; G J Kilpatrick; S Wille; R L Hauger
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

9.  Influence of peptide CRF receptor antagonists upon the behavioural effects of human/rat CRF.

Authors:  D N Jones; R Kortekaas; P D Hatcher; D N Middlemiss; A White; J J Hagan
Journal:  Eur J Pharmacol       Date:  1999-06-04       Impact factor: 4.432

10.  Behavioral effects of central administration of the novel CRF antagonist astressin in rats.

Authors:  M G Spina; A M Basso; E P Zorrilla; C J Heyser; J Rivier; W Vale; E Merlo-Pich; G F Koob
Journal:  Neuropsychopharmacology       Date:  2000-03       Impact factor: 7.853

View more
  58 in total

1.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

Review 2.  Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy.

Authors:  Richard L Hauger; J Alberto Olivares-Reyes; Frank M Dautzenberg; James B Lohr; Sandra Braun; Robert H Oakley
Journal:  Neuropharmacology       Date:  2011-11-25       Impact factor: 5.250

3.  Interactions between corticotropin-releasing factor and the serotonin 1A receptor system on acoustic startle amplitude and prepulse inhibition of the startle response in two rat strains.

Authors:  Lisa H Conti
Journal:  Neuropharmacology       Date:  2011-08-02       Impact factor: 5.250

4.  Susceptibility to PTSD-like behavior is mediated by corticotropin-releasing factor receptor type 2 levels in the bed nucleus of the stria terminalis.

Authors:  Maya Lebow; Adi Neufeld-Cohen; Yael Kuperman; Michael Tsoory; Shosh Gil; Alon Chen
Journal:  J Neurosci       Date:  2012-05-16       Impact factor: 6.167

5.  Restraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptor.

Authors:  Jane E Sutherland; Lisa H Conti
Journal:  Neuropharmacology       Date:  2010-12-23       Impact factor: 5.250

6.  Enduring sensorimotor gating abnormalities following predator exposure or corticotropin-releasing factor in rats: a model for PTSD-like information-processing deficits?

Authors:  Vaishali P Bakshi; Karen M Alsene; Patrick H Roseboom; Elenora E Connors
Journal:  Neuropharmacology       Date:  2011-02-01       Impact factor: 5.250

7.  Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice.

Authors:  Mate Toth; Jodi E Gresack; Debra A Bangasser; Zach Plona; Rita J Valentino; Elizabeth I Flandreau; Isabelle M Mansuy; Emilio Merlo-Pich; Mark A Geyer; Victoria B Risbrough
Journal:  Neuropsychopharmacology       Date:  2013-12-11       Impact factor: 7.853

8.  Exercise-associated changes in the corticosterone response to acute restraint stress: evidence for increased adrenal sensitivity and reduced corticosterone response duration.

Authors:  Brendan D Hare; Jacob A Beierle; Donna J Toufexis; Sayamwong E Hammack; William A Falls
Journal:  Neuropsychopharmacology       Date:  2013-11-26       Impact factor: 7.853

Review 9.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

Review 10.  Role of CRF receptor signaling in stress vulnerability, anxiety, and depression.

Authors:  Richard L Hauger; Victoria Risbrough; Robert H Oakley; J Alberto Olivares-Reyes; Frank M Dautzenberg
Journal:  Ann N Y Acad Sci       Date:  2009-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.